In contrast, we have recently reported that increased systemic level of dermcidin might also contribute to the development of T1DM both in the animal model (7) as well as in humans suffering from coronary artery disease where an acute T1DM like condition is known to develop, albeit temporarily, due to severe impairment of systemic insulin synthesis (6). This evidence concerns the gene INS and type 1 diabetes mellitus.